5 Oversold Healthcare Stocks To Buy Right Now

3. Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH)

Number of Hedge Fund Holders: 18

14-day RSI as of March 12: 28.23

On March 5, JPMorgan analysts initiated coverage on Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) with an Overweight rating and a $60 price target.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) is a pharmaceutical company. It develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products.

At the end of the fourth quarter, 18 hedge funds were long Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), with a total stake value of $111.9 million.

Follow Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH)